Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
74.86%
Operating Margin
48.89%
Net Margin
39.89%
Efficiency Metrics
Revenue per Expense Ratio
1.96
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
4.05%
EPS
0.8100000000
Balance Sheet Analysis
Current Ratio
2.19
Cash Ratio
2.14
Working Capital
$565.63M
Debt to Equity
2.07
Debt to Assets
57.64%
Equity Ratio
27.81%
Cash Flow Analysis
Operating Cash Flow Ratio
71.25%
Free Cash Flow Ratio
69.52%
CapEx to Revenue
1.73%
Dividends Paid
$116.42M
Stock Buybacks
$2.48M
Total Shareholder Returns
$118.90M
Cash Position Change
63.12%
Key Takeaways (2023 FY)
Revenue declined by 25.367720661838%, indicating potential market challenges
Increased dividend payments by 8.47%
Detailed Growth Metrics
Core Performance
Revenue
-25.37%
Net Income
-28.89%
EPS
-28.95%
Operating Income
-63.65%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-16.11%
Operating Cash Flow
69.25%
Free Cash Flow
81.04%
Balance Sheet Health
Assets
-7.37%
Debt
-25.16%
Book Value per Share
-0.38%
Inventory
100.00%
Shareholder Returns
Dividends per Share
8.47%
Shares Outstanding
0.29%
Long Term Trends
3Y Revenue/Share
88.88%
5Y Revenue/Share
-50.50%
3Y Dividend/Share
-11.71%
5Y Dividend/Share
-26.05%